Cargando…

Ethical Concerns Regarding High-Dose Enoxaparin for Venous Thromboembolism Prevention in Plastic Surgery Patients

Detalles Bibliográficos
Autor principal:	Swanson, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756668/ https://www.ncbi.nlm.nih.gov/pubmed/31592395 http://dx.doi.org/10.1097/GOX.0000000000002485

Ejemplares similares

Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
por: Swanson, Eric
Publicado: (2013)

Ultrasound Surveillance Offers a Safe and Effective Method for Venous Thromboembolism Prevention in Plastic Surgery Patients
por: Swanson, Eric
Publicado: (2020)

Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013)

Reconsidering the value of Caprini scores and venous thromboembolism (VTE) risk mitigation methods in plastic surgery patients
por: Swanson, Eric
Publicado: (2023)

A New Approach for Venous Thromboembolism Prevention in Plastic Surgery
por: Swanson, Eric
Publicado: (2022)

Ethical concerns regarding intersex
por: Aslam, Hafiz Muhammad, et al.
Publicado: (2013)

Reconsidering the Role of Routine Anticoagulation for Venous Thromboembolism Prevention in Plastic Surgery
por: Swanson, Eric
Publicado: (2020)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Abstract: Venous Thromboembolism Prevention Using Twice Daily Enoxaparin in Plastic Surgery Patients: A Prospective Clinical Trial
por: Pannucci, Christopher J., et al.
Publicado: (2017)

Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery
por: Nomura, Takeo, et al.
Publicado: (2013)

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019)

Are Caprini Scores and Chemoprophylaxis Necessary to Reduce the Risk of Venous Thromboembolism after Abdominoplasty?
por: Swanson, Eric
Publicado: (2023)

Ethical Concerns Regarding the Use of Large Language Models in Healthcare
por: Lareyre, Fabien, et al.
Publicado: (2023)

Direct Oral Anticoagulants Vs. Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose–Response Meta‐analysis
por: Boyd, RA, et al.
Publicado: (2017)

Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)

Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran
por: Abutorabi, Ali, et al.
Publicado: (2023)

Bemiparin versus Enoxaparin in the Prevention of Venous Thromboembolism among Intensive Care Unit Patients
por: Abbas, Mohamed Sayed
Publicado: (2017)

The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
por: Altawil, Esraa, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery
por: Huang, Qiang, et al.
Publicado: (2019)

Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial
por: Dziri, Chadli, et al.
Publicado: (2023)

Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer: A meta-analysis
por: Xing, Jiali, et al.
Publicado: (2018)

Reply: The Limitations of Psychometric Outcome Studies in Plastic Surgery
por: Swanson, Eric
Publicado: (2015)

Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review
por: Hoffman, Stephanie, et al.
Publicado: (2017)

Outcome Studies in Plastic Surgery: Knowing the Objectives and Avoiding Pitfalls
por: Swanson, Eric
Publicado: (2015)

Safety and Effectiveness of Reduced Dose Versus Standard Dose Enoxaparin Venous Thromboembolism Prophylaxis in Underweight Medically Ill Patients
por: Nemeth, Abigail, et al.
Publicado: (2022)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis
por: Huang, Hai-Feng, et al.
Publicado: (2018)

Secondary Polycythemia and the Risk of Venous Thromboembolism
por: Bhatt, Vijaya Raj
Publicado: (2014)

Obesity, pregnancy, and prophylaxis for venous thromboembolism
por: Nawaz, Iqra, et al.
Publicado: (2023)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Ethical considerations regarding head transplantation
por: Čartolovni, Anto, et al.
Publicado: (2015)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial
por: Mirdamadi, Ahmad, et al.
Publicado: (2014)

Omalizumab as a Provoking Factor for Venous Thromboembolism
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2019)

Once-daily vs. twice-daily dosing of enoxaparin for the management of venous thromboembolism: A systematic review and meta-analysis
por: Niu, Jingrong, et al.
Publicado: (2020)

Concern regarding quality and quality of muscle
por: Saitoh, Masakazu, et al.
Publicado: (2015)

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients
por: Boyd, Allison, et al.
Publicado: (2023)

Response: Patient and caregiver engagement in venous thromboembolism research
por: Barnes, Geoffrey D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hepk3vhhip5m5692aitmf9i4sa